Patents
Literature
1 results about "Anti-diabetic Agent" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Any substance used to reduce hyperglycemia or treat disorders associated with diabetes. Based on their mechanism of action, this class of agents can be classified to the following groups: directly acting insulomimetics, which activates insulin receptors; indirectly acting insulinomimetics, which increase insulin release such as sulfonylureas or which potentiate the effect of insulin such as metformin; those act directly on the metabolism of glucose such as inhibitors of glucosidases and inhibitors of aldose reductase.
An alpha-glucosidase inhibitor and its preparation method and application
The application discloses a natural alpha-glucosidase inhibitor and a preparation method and application thereof, and the natural alpha-glucosidase inhibitor is 3,3'-dimethoxy ellagic acid extracted from a sapium sebiferum. The application is specifically implemented according to the following steps: preparing a sapium sebiferum extract; and separating and purifying the sapium sebiferum extract to obtain 3,3'-dimethoxy ellagic acid. The application obtains a novel natural alpha-glucosidase inhibitor 3,3'-dimethoxy ellagic acid, and the inhibition effect of the 3,3'-dimethoxy ellagic acid on alpha-glucosidase is obvious at a concentration of 4 mg / mL, so that the 3,3'-dimethoxy ellagic acid provides a lead compound for research and development of a novel natural anti-diabetic drug.
Owner:XIAN UNIV OF TECH